About LENZ Therapeutics, Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
Market Cap
$0.72B
Employees
42
Listed Since
March 22, 2024
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Website
www.lenz-tx.comPhone
858-925-7000
Headquarters
201 LOMAS SANTA FE DRIVE, SUITE 300
SOLANA BEACH, CA 92075
CIK
0001815776